Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ocumetics TechnologyFRA:2QB0 -2.84%36 14-Day RSI is 53.27 as of Jul. 28, 2026. GuruFocus rates FRA:2QB0 with a GF Score™ of 36/100. The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Ocumetics Technology ranks worse than 67.32% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for Ocumetics Technology's 14-Day RSI or its related term are showing as below:
FRA:2QB0's 14-Day RSI is ranked worse than 67.32% of 866
companies
in the Medical Devices & Instruments industry
Industry Median: 46.6
vs FRA:2QB0: 53.27
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Ocumetics Technology 14-Day RSI Related Terms
FRA:2QB0 vs ISRG, BDX, MDLN: 14-Day RSI Comparison
For the Medical Instruments & Supplies subindustry, Ocumetics Technology's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ocumetics Technology 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ocumetics Technology's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Ocumetics Technology's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocumetics Technology (FRA:2QB0) has a 14-Day RSI of 53.27 as of Jul. 28, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Ocumetics Technology and its competitors. According to the industry distribution chart, Ocumetics Technology ranks #583 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 67.3%.
Is Ocumetics Technology's 14-Day RSI too high?
Ocumetics Technology's current 14-Day RSI is 53.27. The Medical Devices & Instruments industry median 14-Day RSI is 46.60. Ocumetics Technology's value of 53.27 is 14.3% above this industry median. Based on the distribution chart, Ocumetics Technology ranks #583 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ocumetics Technology has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Ocumetics Technology's 14-Day RSI compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ocumetics Technology ranks #583 out of 866 companies for 14-Day RSI. This places Ocumetics Technology in the lower half of its industry. The industry median 14-Day RSI is 46.60. Ocumetics Technology's value of 53.27 is 14.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 46.60, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ocumetics Technology's current 14-Day RSI of 53.27 is 14.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Ocumetics Technology and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 46.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocumetics Technology's current 14-Day RSI is 53.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocumetics Technology stock overvalued right now?
Ocumetics Technology (FRA:2QB0) has a current 14-Day RSI of 53.27. The current 14-Day RSI is 53.27 and 14.3% above the Medical Devices & Instruments industry median of 46.60. Ocumetics Technology's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Ocumetics Technology (FRA:2QB0), the current 14-Day RSI is 53.27 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ocumetics Technology Corp is a Canadian research and product development company that specializes in adaptive lens designs. The company is engaged in developing an accommodating intraocular lens to eliminate the need for corrective lenses. The company is in the process of developing new lens technology, which is expected to link nerve impulses with the natural mechanisms for accommodation within the human eye.
36GF Score
Get the complete analysis for FRA:2QB0
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2QB0 has been successfully added to your 
